Becker's Healthcare September 5, 2025
Paige Twenter

The FDA said Sept. 4 it will release complete response letters, or product rejection letters, “promptly after they are issued” to manufacturers.

The agency also published 89 previously unreleased complete response letters related to pending or withdrawn applications. The letters cite the FDA’s safety and effectiveness concerns with each product.

“This is a milestone day for the agency,” FDA Commissioner Marty Makary, MD,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies
FDA guidance eases wearables oversight. But experts have questions about what’s next.
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter

Share Article